BE904223A - Association renfermant a titre de principes actifs, un analgesique central et l'adenine. - Google Patents

Association renfermant a titre de principes actifs, un analgesique central et l'adenine.

Info

Publication number
BE904223A
BE904223A BE0/216263A BE216263A BE904223A BE 904223 A BE904223 A BE 904223A BE 0/216263 A BE0/216263 A BE 0/216263A BE 216263 A BE216263 A BE 216263A BE 904223 A BE904223 A BE 904223A
Authority
BE
Belgium
Prior art keywords
adenine
analgesic
active ingredients
central analgesic
combination containing
Prior art date
Application number
BE0/216263A
Other languages
English (en)
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of BE904223A publication Critical patent/BE904223A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Association renfermant un analgésique central et l'adénine pour une méthode de traitement analgésique du corps humain ou animal. L'analgésique central est la morphine, la péthidine, la pentazocine, la dextromoramide. L'adénine associée à cet analgésique central, augmente son effet analgésique de manière importante.
BE0/216263A 1985-02-14 1986-02-13 Association renfermant a titre de principes actifs, un analgesique central et l'adenine. BE904223A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8502098A FR2577422B1 (fr) 1985-02-14 1985-02-14 Association renfermant a titre de principes actifs, un analgesique central et l'adenine ou l'adenosine ou l'un des analogues de l'adenosine

Publications (1)

Publication Number Publication Date
BE904223A true BE904223A (fr) 1986-08-13

Family

ID=9316262

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/216263A BE904223A (fr) 1985-02-14 1986-02-13 Association renfermant a titre de principes actifs, un analgesique central et l'adenine.

Country Status (12)

Country Link
US (1) US4760070A (fr)
JP (1) JPS61189222A (fr)
AU (1) AU593785B2 (fr)
BE (1) BE904223A (fr)
CH (1) CH667809A5 (fr)
DE (1) DE3604683A1 (fr)
FR (1) FR2577422B1 (fr)
GB (1) GB2171305B (fr)
IT (1) IT1190194B (fr)
LU (1) LU86305A1 (fr)
NL (1) NL8600381A (fr)
ZA (1) ZA86774B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2082527C (fr) * 1990-05-10 1998-07-28 Research And Education Institute, Inc. Utilisation de derives de purine pour l'anesthesie, l'analgesie et la conservation d'organe in vivo
US5679650A (en) * 1993-11-24 1997-10-21 Fukunaga; Atsuo F. Pharmaceutical compositions including mixtures of an adenosine compound and a catecholamine

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2610985A1 (de) * 1976-03-16 1977-09-29 Byk Gulden Lomberg Chem Fab Arzneimittel enthaltend beta-d-1 (6-amino-9h-purin-9-yl)-1-deoxyribofuranuronsaeurederivate
FR2534809B1 (fr) * 1982-10-26 1985-06-28 Roussel Uclaf Association medicamenteuse, renfermant a titre de principes actifs, un analgesique central et la vitamine b 12 ou un derive de celle-ci

Also Published As

Publication number Publication date
LU86305A1 (fr) 1986-09-02
CH667809A5 (fr) 1988-11-15
AU5367786A (en) 1986-08-21
JPS61189222A (ja) 1986-08-22
IT8647656A0 (it) 1986-02-13
IT1190194B (it) 1988-02-16
GB2171305A (en) 1986-08-28
US4760070A (en) 1988-07-26
GB2171305B (en) 1989-01-25
FR2577422A1 (fr) 1986-08-22
AU593785B2 (en) 1990-02-22
GB8603530D0 (en) 1986-03-19
NL8600381A (nl) 1986-09-01
ZA86774B (en) 1987-04-29
DE3604683A1 (de) 1986-08-14
FR2577422B1 (fr) 1988-10-28

Similar Documents

Publication Publication Date Title
DE3587203D1 (de) Mittel zur mundhygiene.
DE10199020I2 (de) Galanthamin oder dessen Analoge zur Behandlung derAlzheimerschen Krankheit.
ATE122885T1 (de) Mittel zur behandlung von herzerkrankungen.
BE902783A (fr) Appareil et procede pour l'administration pulsee d'agents favorisant la croissance.
DE3684190D1 (de) Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
CA2285203A1 (fr) Compositions contenant de la capsaicine ou des analogues de capsaicine et un anesthesique local
ATE203907T1 (de) Dermatologische zubereitung zur behandlung von aktinischen keratosen
ATE78171T1 (de) Gangliosidgemisch zur verwendung als therapeutisches hilfsmittel zur schmerzunterdrueckung bei peripheren neuropathien.
SE8505920D0 (sv) New protein and its use
ATE148628T1 (de) 5-methylisoxazol-4-carbonsäure-anilide und 2- hydroxyethyliden-cyanoessigsäure-anilide zur behandlung von augenkrankheiten
BE904223A (fr) Association renfermant a titre de principes actifs, un analgesique central et l'adenine.
DE69330429D1 (de) Verfahren zur behandlung von haarausfall
DE69623316D1 (de) Ctla-8 in kombination mit g-csf oder mit g-csf und il-6, und verwendung vom ctla-8 zur behandlung von infektionen
NO179245C (no) Arylalkylestere av 4,5-dihydroksy-9,10-dihydro-9,10-diokso-2-antracenkarboksylsyre med terapeutisk aktivitet
NO830041L (no) Fremgangsmaate til behandling av azykli hos sauer eller storfe
ES8603270A1 (es) Procedimiento para preparar liposomas que contiene alergenoso fracciones de alergenos inhalables
GEP20012377B (en) Use of Trophoblastic Beta-1 Glycoprotein for Treating Auto-Immune Diseases and Method of Treatment These Diseases
ATE70444T1 (de) Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
PT80008A (en) A process for the preparations of a 2alpha-cyano-4alpha,alpha5--epoxyandrostan-3,17-dione
UA10200A (uk) Спосіб лікування хронічного алкоголізму а.т.філатова - с.і.жижильова
FR2368269A1 (fr) Compositions en vue d'applications capillaires
DE59603099D1 (de) Transdermales therapeutisches system für silatranverbindungen
ATE153533T1 (de) Zubereitungen, die acyclovir-ähnliche verbindungen und 2'-vinylsubstituierte nukleosidanaloge enthalten, zur behandlung viraler infektionen
UA28288A (uk) Спосіб лікування шизофренії
RO69873A2 (fr) Methode pour le traitement des affections d'appareil locomoteur,d'appareil respirateur,du systeme nerveux periferique et des maladies gynecologiques et de peaux

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: ROUSSEL-UCLAF

Effective date: 19930228